data_1rot_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rot _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.213 0 CA-C-O 119.718 -0.49 . . . . 0.0 114.216 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.38 164.06 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -168.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -148.05 143.13 27.0 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 123.314 1.531 . . . . 0.0 112.731 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.263 6.4 tp -147.66 76.01 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.88 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.561 ' HB2' ' H ' ' A' ' 32' ' ' VAL . 1.3 t -159.72 -62.98 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.258 0 CA-C-O 115.363 -2.256 . . . . 0.0 114.928 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.77 22.87 0.2 Allowed 'Trans proline' 0 CA--C 1.587 3.161 0 CA-C-N 126.055 3.198 . . . . 0.0 115.19 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -132.26 -72.46 0.53 Allowed 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 126.158 1.783 . . . . 0.0 109.638 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -93.19 -17.76 23.33 Favored 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.563 0.0 OUTLIER 87.0 27.69 0.04 OUTLIER 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.07 31.51 0.98 Allowed 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.48 25.66 8.94 Favored Glycine 0 N--CA 1.489 2.194 1 N-CA-C 124.502 4.561 . . . . 0.0 124.502 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.561 ' H ' ' HB2' ' A' ' 25' ' ' SER . 10.5 p -160.96 148.92 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.135 1 CA-C-N 124.218 4.009 . . . . 0.0 119.775 -177.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -121.58 111.28 17.04 Favored 'General case' 0 CA--C 1.585 2.322 0 C-N-CA 126.74 2.016 . . . . 0.0 106.639 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.8 114.5 28.75 Favored 'General case' 0 C--N 1.372 1.575 0 CA-C-N 124.44 3.291 . . . . 0.0 108.504 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.5 t -86.18 129.92 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.265 -0.897 . . . . 0.0 111.213 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.469 HD12 ' SG ' ' A' ' 102' ' ' CYS 0.285 0.5 OUTLIER -87.36 123.93 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.408 1.099 . . . . 0.0 108.991 174.626 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -115.76 -52.26 2.63 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.222 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -114.68 100.41 8.24 Favored 'General case' 0 CA--C 1.591 2.544 0 N-CA-C 102.144 -3.28 . . . . 0.0 102.144 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . 0.254 6.3 pt-20 -42.69 -90.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 1 N-CA-C 123.84 4.755 . . . . 0.0 123.84 -178.598 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.0 158.22 29.52 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 127.084 2.278 . . . . 0.0 111.756 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.275 14.6 t -145.29 -32.24 0.39 Allowed 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.3 -106.87 1.0 Allowed Glycine 0 CA--C 1.542 1.734 0 N-CA-C 117.264 1.665 . . . . 0.0 117.264 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -146.06 95.14 2.58 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.934 1.294 . . . . 0.0 108.224 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.322 74.9 mt-10 73.29 175.76 0.27 Allowed 'General case' 0 N--CA 1.496 1.83 1 N-CA-C 123.163 4.505 . . . . 0.0 123.163 171.61 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.7 p -96.2 152.89 39.11 Favored Pre-proline 0 CA--C 1.572 1.789 0 CA-C-N 113.346 -1.752 . . . . 0.0 113.156 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.17 172.29 16.33 Favored 'Trans proline' 0 CA--C 1.572 2.414 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.1 ptm -112.97 166.54 11.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.712 -1.243 . . . . 0.0 114.018 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.302 0.4 OUTLIER -63.81 131.57 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 O-C-N 119.375 -2.078 . . . . 0.0 109.406 176.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.4 12.58 75.45 Favored Glycine 0 CA--C 1.568 3.36 0 N-CA-C 117.725 1.85 . . . . 0.0 117.725 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -83.22 144.87 29.49 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.765 1.782 . . . . 0.0 114.232 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.3 tpt85 -83.65 127.38 33.72 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 m -130.51 142.45 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 119.257 0.935 . . . . 0.0 111.743 -172.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -116.71 104.07 10.99 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 120.223 -1.548 . . . . 0.0 107.798 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -106.59 170.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 123.326 1.536 . . . . 0.0 114.662 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.86 116.47 10.78 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 168.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.252 10.2 p90 -114.86 148.98 37.84 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -174.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.9 m -120.03 146.26 46.06 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 163.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.5 141.8 8.64 Favored Glycine 0 CA--C 1.549 2.217 0 O-C-N 119.395 -2.066 . . . . 0.0 116.246 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -130.21 149.55 51.86 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.095 2.158 . . . . 0.0 114.312 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.2 tp -80.85 168.27 18.96 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.93 1.348 . . . . 0.0 107.946 168.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.298 0.0 OUTLIER -60.42 -27.34 67.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.233 2.309 . . . . 0.0 117.233 178.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -74.07 3.31 7.16 Favored 'General case' 0 CA--C 1.595 2.688 0 N-CA-C 114.438 1.274 . . . . 0.0 114.438 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.56 42.12 18.54 Favored Glycine 0 N--CA 1.504 3.178 0 O-C-N 119.914 -1.741 . . . . 0.0 114.185 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.6 m -116.93 115.59 25.77 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -78.58 92.81 4.74 Favored 'General case' 0 CA--C 1.588 2.424 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -67.91 -32.31 72.69 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 119.014 -2.304 . . . . 0.0 114.988 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.622 ' HD2' ' NE ' ' A' ' 72' ' ' ARG . 15.6 t70 -148.11 153.0 38.28 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 124.449 2.071 . . . . 0.0 112.571 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.9 p -155.62 90.85 1.26 Allowed 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 112.746 -2.025 . . . . 0.0 109.172 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 t -54.82 -34.45 62.82 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -53.07 -41.48 64.92 Favored 'General case' 0 CA--C 1.583 2.234 0 C-N-CA 125.99 1.716 . . . . 0.0 114.316 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.99 -39.04 30.88 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 124.908 1.283 . . . . 0.0 114.151 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.622 ' NE ' ' HD2' ' A' ' 67' ' ' ASP . 36.0 mtm105 -61.65 -20.77 63.77 Favored 'General case' 0 CA--C 1.578 2.056 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.371 3.1 ttmp? 107.24 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 127.425 2.29 . . . . 0.0 113.482 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.51 171.9 9.09 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 123.714 1.721 . . . . 0.0 112.339 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -99.16 -177.1 3.5 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.113 -1.403 . . . . 0.0 114.035 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.287 4.9 t80 -116.07 152.22 34.01 Favored 'General case' 0 CA--C 1.581 2.161 0 O-C-N 120.847 -1.158 . . . . 0.0 109.686 173.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.8 p -161.57 137.53 7.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 118.576 -2.577 . . . . 0.0 109.257 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -147.61 -175.8 5.0 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.429 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -127.52 119.76 26.76 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.01 106.49 0.08 Allowed 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 125.858 1.663 . . . . 0.0 113.479 -175.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.98 40.19 98.56 Favored Glycine 0 N--CA 1.513 3.773 0 N-CA-C 116.871 1.508 . . . . 0.0 116.871 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.84 -68.05 0.87 Allowed 'General case' 0 N--CA 1.506 2.374 0 CA-C-N 117.454 0.627 . . . . 0.0 112.638 -174.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.95 -58.78 2.57 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 126.012 3.007 . . . . 0.0 108.741 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HB2' ' HE2' ' A' ' 84' ' ' GLU 0.652 51.8 tp10 95.77 138.02 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.101 2 CA-C-N 107.241 -4.48 . . . . 0.0 116.576 165.176 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.338 30.4 m -95.94 -122.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 1 CA-C-N 103.667 -6.152 . . . . 0.0 107.183 -174.35 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.9 pt -117.43 155.85 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 123.552 1.644 . . . . 0.0 108.624 169.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.261 2.5 mptt -64.67 -32.58 74.31 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.079 -1.419 . . . . 0.0 113.733 177.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.75 -35.28 76.0 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 117.266 -1.349 . . . . 0.0 111.652 167.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -73.51 -45.17 55.42 Favored 'General case' 0 C--N 1.365 1.24 0 CA-C-N 120.896 1.68 . . . . 0.0 112.627 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.19 -38.21 73.32 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-N 120.379 1.445 . . . . 0.0 114.396 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.293 1.6 mp -67.59 -58.15 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.961 0 CA-C-N 119.547 1.067 . . . . 0.0 111.258 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.67 -41.34 97.42 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.265 4.9 t -63.31 -45.08 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 CA-C-N 120.235 1.379 . . . . 0.0 111.714 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.53 -38.03 29.22 Favored 'General case' 0 CA--C 1.583 2.212 0 CA-C-N 120.746 1.612 . . . . 0.0 114.438 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.8 p -91.79 17.47 9.0 Favored 'General case' 0 CA--C 1.596 2.729 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 16.2 ttt -111.44 141.34 45.12 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 119.215 -2.178 . . . . 0.0 114.883 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -98.0 150.46 21.36 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 116.407 2.002 . . . . 0.0 116.407 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.9 t -42.69 116.43 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.584 2.281 0 C-N-CA 125.515 1.526 . . . . 0.0 114.068 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.05 -35.44 4.44 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 118.888 2.315 . . . . 0.0 118.888 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.428 7.2 mt-10 -95.6 -154.28 0.43 Allowed 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 -175.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -149.14 155.74 41.13 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 119.225 3.046 . . . . 0.0 119.225 -170.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.484 ' H ' HD23 ' A' ' 101' ' ' LEU . 3.6 m -145.64 153.7 41.31 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 112.177 -2.283 . . . . 0.0 113.134 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -110.84 122.59 48.24 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-O 124.726 2.203 . . . . 0.0 109.016 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 mt -83.45 130.27 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 CA-C-N 112.106 -2.315 . . . . 0.0 109.9 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.6 m -126.59 98.61 5.47 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 5.4 p -124.89 148.81 48.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -171.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -79.87 146.81 64.91 Favored Pre-proline 0 CA--C 1.58 2.131 0 CA-C-N 113.537 -1.665 . . . . 0.0 112.594 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -51.3 -19.86 7.21 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 N-CA-C 119.706 2.925 . . . . 0.0 119.706 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.15 -42.87 91.73 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 119.744 1.156 . . . . 0.0 113.739 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -85.77 7.12 24.95 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.907 1.283 . . . . 0.0 114.164 172.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.26 -120.0 0.09 Allowed 'General case' 0 CA--C 1.585 2.3 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.262 4.0 m-85 -84.84 -2.78 58.19 Favored 'General case' 0 N--CA 1.521 3.085 0 CA-C-N 121.364 1.893 . . . . 0.0 115.007 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.2 -33.02 5.32 Favored Glycine 0 N--CA 1.502 3.065 1 N-CA-C 123.127 4.011 . . . . 0.0 123.127 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.0 t -64.98 -49.77 68.98 Favored 'General case' 0 CA--C 1.575 1.919 0 CA-C-N 119.965 1.882 . . . . 0.0 114.109 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -126.17 -16.43 5.51 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 118.977 2.954 . . . . 0.0 118.977 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.5 149.65 21.45 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-N 122.809 2.55 . . . . 0.0 113.235 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.3 t -82.26 118.13 70.87 Favored Pre-proline 0 CA--C 1.58 2.111 0 CA-C-O 117.001 -1.476 . . . . 0.0 108.716 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -33.03 -48.18 0.37 Allowed 'Trans proline' 0 CA--C 1.579 2.751 1 N-CA-C 123.398 4.345 . . . . 0.0 123.398 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.96 -24.65 8.2 Favored 'Trans proline' 0 CA--C 1.574 2.5 0 CA-C-N 125.492 2.997 . . . . 0.0 118.933 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -152.01 -20.21 0.18 Allowed 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 118.969 2.952 . . . . 0.0 118.969 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.3 mt -96.37 129.76 32.6 Favored Pre-proline 0 N--CA 1.503 2.176 0 CA-C-N 121.826 2.103 . . . . 0.0 114.603 -170.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -96.12 172.98 1.0 Allowed 'Trans proline' 0 CA--C 1.593 3.447 0 C-N-CA 122.585 2.19 . . . . 0.0 112.688 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -55.73 -0.02 0.16 Allowed 'Trans proline' 0 CA--C 1.577 2.653 1 N-CA-C 122.58 4.031 . . . . 0.0 122.58 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -144.64 65.85 1.27 Allowed 'General case' 0 CA--C 1.582 2.182 0 CA-C-N 121.193 1.815 . . . . 0.0 112.487 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.04 110.74 7.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.019 -1.676 . . . . 0.0 109.57 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 88.7 m -59.5 156.92 12.28 Favored 'General case' 0 CA--C 1.588 2.431 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.3 mt -127.72 166.84 17.38 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 124.647 2.165 . . . . 0.0 114.371 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 51.8 t -143.35 115.69 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.861 0 CA-C-N 111.825 -2.443 . . . . 0.0 108.04 -173.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.282 2.5 m-85 -129.97 126.63 38.26 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-N 122.497 2.408 . . . . 0.0 110.904 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -99.19 105.0 17.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 119.494 -2.004 . . . . 0.0 105.966 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 t -115.65 129.38 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 122.138 0.971 . . . . 0.0 112.0 -170.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -100.57 144.28 29.73 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.719 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 44.0 tp -127.94 122.2 31.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.587 -0.696 . . . . 0.0 109.582 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -92.41 -48.44 6.65 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -160.48 158.85 30.03 Favored 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 125.445 1.498 . . . . 0.0 108.998 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.254 2.9 p90 -147.36 -90.49 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 110.305 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.425 80.1 tttt -114.73 -65.97 1.13 Allowed 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-N 125.557 3.799 . . . . 0.0 117.837 -178.545 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.213 0 CA-C-O 119.718 -0.49 . . . . 0.0 114.216 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.38 164.06 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -168.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -148.05 143.13 27.0 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 123.314 1.531 . . . . 0.0 112.731 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.263 6.4 tp -147.66 76.01 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.88 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.546 ' HB2' ' H ' ' A' ' 32' ' ' VAL . 1.3 t -159.72 -62.98 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.258 0 CA-C-O 115.363 -2.256 . . . . 0.0 114.928 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.77 22.87 0.2 Allowed 'Trans proline' 0 CA--C 1.587 3.161 0 CA-C-N 126.055 3.198 . . . . 0.0 115.19 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.26 -72.46 0.53 Allowed 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 126.158 1.783 . . . . 0.0 109.638 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -93.19 -17.76 23.33 Favored 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.563 0.0 OUTLIER 87.0 27.69 0.04 OUTLIER 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.07 31.51 0.98 Allowed 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.48 25.66 8.94 Favored Glycine 0 N--CA 1.489 2.194 1 N-CA-C 124.502 4.561 . . . . 0.0 124.502 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.546 ' H ' ' HB2' ' A' ' 25' ' ' SER . 10.5 p -160.96 148.92 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.135 1 CA-C-N 124.218 4.009 . . . . 0.0 119.775 -177.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -121.58 111.28 17.04 Favored 'General case' 0 CA--C 1.585 2.322 0 C-N-CA 126.74 2.016 . . . . 0.0 106.639 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.8 114.5 28.75 Favored 'General case' 0 C--N 1.372 1.575 0 CA-C-N 124.44 3.291 . . . . 0.0 108.504 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.5 t -86.18 129.92 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.265 -0.897 . . . . 0.0 111.213 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 39' ' ' GLU 0.285 0.5 OUTLIER -87.36 123.93 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.408 1.099 . . . . 0.0 108.991 174.626 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -115.76 -52.26 2.63 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.222 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -114.68 100.41 8.24 Favored 'General case' 0 CA--C 1.591 2.544 0 N-CA-C 102.144 -3.28 . . . . 0.0 102.144 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 36' ' ' ILE 0.254 6.3 pt-20 -42.69 -90.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 1 N-CA-C 123.84 4.755 . . . . 0.0 123.84 -178.598 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.0 158.22 29.52 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 127.084 2.278 . . . . 0.0 111.756 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.275 14.6 t -145.29 -32.24 0.39 Allowed 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.3 -106.87 1.0 Allowed Glycine 0 CA--C 1.542 1.734 0 N-CA-C 117.264 1.665 . . . . 0.0 117.264 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -146.06 95.14 2.58 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.934 1.294 . . . . 0.0 108.224 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.322 74.9 mt-10 73.29 175.76 0.27 Allowed 'General case' 0 N--CA 1.496 1.83 1 N-CA-C 123.163 4.505 . . . . 0.0 123.163 171.61 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.7 p -96.2 152.89 39.11 Favored Pre-proline 0 CA--C 1.572 1.789 0 CA-C-N 113.346 -1.752 . . . . 0.0 113.156 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.17 172.29 16.33 Favored 'Trans proline' 0 CA--C 1.572 2.414 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.1 ptm -112.97 166.54 11.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.712 -1.243 . . . . 0.0 114.018 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.302 0.4 OUTLIER -63.81 131.57 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 O-C-N 119.375 -2.078 . . . . 0.0 109.406 176.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.4 12.58 75.45 Favored Glycine 0 CA--C 1.568 3.36 0 N-CA-C 117.725 1.85 . . . . 0.0 117.725 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -83.22 144.87 29.49 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.765 1.782 . . . . 0.0 114.232 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.3 tpt85 -83.65 127.38 33.72 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 m -130.51 142.45 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 119.257 0.935 . . . . 0.0 111.743 -172.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -116.71 104.07 10.99 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 120.223 -1.548 . . . . 0.0 107.798 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.9 m -106.59 170.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 123.326 1.536 . . . . 0.0 114.662 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.86 116.47 10.78 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 168.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.252 10.2 p90 -114.86 148.98 37.84 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -174.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.9 m -120.03 146.26 46.06 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 163.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.5 141.8 8.64 Favored Glycine 0 CA--C 1.549 2.217 0 O-C-N 119.395 -2.066 . . . . 0.0 116.246 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -130.21 149.55 51.86 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.095 2.158 . . . . 0.0 114.312 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.2 tp -80.85 168.27 18.96 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.93 1.348 . . . . 0.0 107.946 168.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.298 0.0 OUTLIER -60.42 -27.34 67.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.233 2.309 . . . . 0.0 117.233 178.522 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -74.07 3.31 7.16 Favored 'General case' 0 CA--C 1.595 2.688 0 N-CA-C 114.438 1.274 . . . . 0.0 114.438 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.56 42.12 18.54 Favored Glycine 0 N--CA 1.504 3.178 0 O-C-N 119.914 -1.741 . . . . 0.0 114.185 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.6 m -116.93 115.59 25.77 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -78.58 92.81 4.74 Favored 'General case' 0 CA--C 1.588 2.424 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -67.91 -32.31 72.69 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 119.014 -2.304 . . . . 0.0 114.988 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -148.11 153.0 38.28 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 124.449 2.071 . . . . 0.0 112.571 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.9 p -155.62 90.85 1.26 Allowed 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 112.746 -2.025 . . . . 0.0 109.172 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 t -54.82 -34.45 62.82 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -53.07 -41.48 64.92 Favored 'General case' 0 CA--C 1.583 2.234 0 C-N-CA 125.99 1.716 . . . . 0.0 114.316 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.99 -39.04 30.88 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 124.908 1.283 . . . . 0.0 114.151 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -61.65 -20.77 63.77 Favored 'General case' 0 CA--C 1.578 2.056 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.371 3.1 ttmp? 107.24 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 127.425 2.29 . . . . 0.0 113.482 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.51 171.9 9.09 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 123.714 1.721 . . . . 0.0 112.339 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -99.16 -177.1 3.5 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.113 -1.403 . . . . 0.0 114.035 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.287 4.9 t80 -116.07 152.22 34.01 Favored 'General case' 0 CA--C 1.581 2.161 0 O-C-N 120.847 -1.158 . . . . 0.0 109.686 173.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.8 p -161.57 137.53 7.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 118.576 -2.577 . . . . 0.0 109.257 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.487 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.6 p90 -147.61 -175.8 5.0 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.429 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -127.52 119.76 26.76 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.01 106.49 0.08 Allowed 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 125.858 1.663 . . . . 0.0 113.479 -175.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.98 40.19 98.56 Favored Glycine 0 N--CA 1.513 3.773 0 N-CA-C 116.871 1.508 . . . . 0.0 116.871 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.84 -68.05 0.87 Allowed 'General case' 0 N--CA 1.506 2.374 0 CA-C-N 117.454 0.627 . . . . 0.0 112.638 -174.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.95 -58.78 2.57 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 126.012 3.007 . . . . 0.0 108.741 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.652 51.8 tp10 95.77 138.02 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.101 2 CA-C-N 107.241 -4.48 . . . . 0.0 116.576 165.176 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.338 30.4 m -95.94 -122.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 1 CA-C-N 103.667 -6.152 . . . . 0.0 107.183 -174.35 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.437 HG13 ' H ' ' A' ' 89' ' ' TRP . 25.9 pt -117.43 155.85 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 123.552 1.644 . . . . 0.0 108.624 169.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.261 2.5 mptt -64.67 -32.58 74.31 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.079 -1.419 . . . . 0.0 113.733 177.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.75 -35.28 76.0 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 117.266 -1.349 . . . . 0.0 111.652 167.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.437 ' H ' HG13 ' A' ' 86' ' ' ILE . 33.4 m0 -73.51 -45.17 55.42 Favored 'General case' 0 C--N 1.365 1.24 0 CA-C-N 120.896 1.68 . . . . 0.0 112.627 172.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.19 -38.21 73.32 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-N 120.379 1.445 . . . . 0.0 114.396 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.293 1.6 mp -67.59 -58.15 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.961 0 CA-C-N 119.547 1.067 . . . . 0.0 111.258 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.67 -41.34 97.42 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.265 4.9 t -63.31 -45.08 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 CA-C-N 120.235 1.379 . . . . 0.0 111.714 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.53 -38.03 29.22 Favored 'General case' 0 CA--C 1.583 2.212 0 CA-C-N 120.746 1.612 . . . . 0.0 114.438 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.8 p -91.79 17.47 9.0 Favored 'General case' 0 CA--C 1.596 2.729 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 16.2 ttt -111.44 141.34 45.12 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 119.215 -2.178 . . . . 0.0 114.883 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -98.0 150.46 21.36 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 116.407 2.002 . . . . 0.0 116.407 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.9 t -42.69 116.43 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.584 2.281 0 C-N-CA 125.515 1.526 . . . . 0.0 114.068 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.05 -35.44 4.44 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 118.888 2.315 . . . . 0.0 118.888 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.428 7.2 mt-10 -95.6 -154.28 0.43 Allowed 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 -175.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.14 155.74 41.13 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 119.225 3.046 . . . . 0.0 119.225 -170.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.6 m -145.64 153.7 41.31 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 112.177 -2.283 . . . . 0.0 113.134 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -110.84 122.59 48.24 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-O 124.726 2.203 . . . . 0.0 109.016 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 mt -83.45 130.27 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 CA-C-N 112.106 -2.315 . . . . 0.0 109.9 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.6 m -126.59 98.61 5.47 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 5.4 p -124.89 148.81 48.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -171.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -79.87 146.81 64.91 Favored Pre-proline 0 CA--C 1.58 2.131 0 CA-C-N 113.537 -1.665 . . . . 0.0 112.594 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -51.3 -19.86 7.21 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 N-CA-C 119.706 2.925 . . . . 0.0 119.706 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.15 -42.87 91.73 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 119.744 1.156 . . . . 0.0 113.739 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -85.77 7.12 24.95 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.907 1.283 . . . . 0.0 114.164 172.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.26 -120.0 0.09 Allowed 'General case' 0 CA--C 1.585 2.3 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.454 ' CD2' HD11 ' A' ' 127' ' ' LEU 0.262 4.0 m-85 -84.84 -2.78 58.19 Favored 'General case' 0 N--CA 1.521 3.085 0 CA-C-N 121.364 1.893 . . . . 0.0 115.007 -178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.2 -33.02 5.32 Favored Glycine 0 N--CA 1.502 3.065 1 N-CA-C 123.127 4.011 . . . . 0.0 123.127 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.0 t -64.98 -49.77 68.98 Favored 'General case' 0 CA--C 1.575 1.919 0 CA-C-N 119.965 1.882 . . . . 0.0 114.109 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -126.17 -16.43 5.51 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 118.977 2.954 . . . . 0.0 118.977 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.5 149.65 21.45 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-N 122.809 2.55 . . . . 0.0 113.235 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.479 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 5.3 t -82.26 118.13 70.87 Favored Pre-proline 0 CA--C 1.58 2.111 0 CA-C-O 117.001 -1.476 . . . . 0.0 108.716 177.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -33.03 -48.18 0.37 Allowed 'Trans proline' 0 CA--C 1.579 2.751 1 N-CA-C 123.398 4.345 . . . . 0.0 123.398 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.96 -24.65 8.2 Favored 'Trans proline' 0 CA--C 1.574 2.5 0 CA-C-N 125.492 2.997 . . . . 0.0 118.933 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -152.01 -20.21 0.18 Allowed 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 118.969 2.952 . . . . 0.0 118.969 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.479 ' HB ' ' H ' ' A' ' 117' ' ' SER . 88.3 mt -96.37 129.76 32.6 Favored Pre-proline 0 N--CA 1.503 2.176 0 CA-C-N 121.826 2.103 . . . . 0.0 114.603 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -96.12 172.98 1.0 Allowed 'Trans proline' 0 CA--C 1.593 3.447 0 C-N-CA 122.585 2.19 . . . . 0.0 112.688 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -55.73 -0.02 0.16 Allowed 'Trans proline' 0 CA--C 1.577 2.653 1 N-CA-C 122.58 4.031 . . . . 0.0 122.58 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -144.64 65.85 1.27 Allowed 'General case' 0 CA--C 1.582 2.182 0 CA-C-N 121.193 1.815 . . . . 0.0 112.487 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.04 110.74 7.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.019 -1.676 . . . . 0.0 109.57 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 88.7 m -59.5 156.92 12.28 Favored 'General case' 0 CA--C 1.588 2.431 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.454 HD11 ' CD2' ' A' ' 112' ' ' TYR . 97.3 mt -127.72 166.84 17.38 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 124.647 2.165 . . . . 0.0 114.371 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 51.8 t -143.35 115.69 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.861 0 CA-C-N 111.825 -2.443 . . . . 0.0 108.04 -173.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.282 2.5 m-85 -129.97 126.63 38.26 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-N 122.497 2.408 . . . . 0.0 110.904 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -99.19 105.0 17.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 119.494 -2.004 . . . . 0.0 105.966 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 t -115.65 129.38 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 122.138 0.971 . . . . 0.0 112.0 -170.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -100.57 144.28 29.73 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.719 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 44.0 tp -127.94 122.2 31.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.587 -0.696 . . . . 0.0 109.582 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -92.41 -48.44 6.65 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -160.48 158.85 30.03 Favored 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 125.445 1.498 . . . . 0.0 108.998 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.254 2.9 p90 -147.36 -90.49 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 110.305 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.425 80.1 tttt -114.73 -65.97 1.13 Allowed 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-N 125.557 3.799 . . . . 0.0 117.837 -178.545 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.213 0 CA-C-O 119.718 -0.49 . . . . 0.0 114.216 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.38 164.06 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -168.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -148.05 143.13 27.0 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 123.314 1.531 . . . . 0.0 112.731 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.263 6.4 tp -147.66 76.01 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.88 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.546 ' HB2' ' H ' ' A' ' 32' ' ' VAL . 1.3 t -159.72 -62.98 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.258 0 CA-C-O 115.363 -2.256 . . . . 0.0 114.928 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.77 22.87 0.2 Allowed 'Trans proline' 0 CA--C 1.587 3.161 0 CA-C-N 126.055 3.198 . . . . 0.0 115.19 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.26 -72.46 0.53 Allowed 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 126.158 1.783 . . . . 0.0 109.638 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -93.19 -17.76 23.33 Favored 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.563 0.0 OUTLIER 87.0 27.69 0.04 OUTLIER 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.07 31.51 0.98 Allowed 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.48 25.66 8.94 Favored Glycine 0 N--CA 1.489 2.194 1 N-CA-C 124.502 4.561 . . . . 0.0 124.502 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.546 ' H ' ' HB2' ' A' ' 25' ' ' SER . 10.5 p -160.96 148.92 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.135 1 CA-C-N 124.218 4.009 . . . . 0.0 119.775 -177.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -121.58 111.28 17.04 Favored 'General case' 0 CA--C 1.585 2.322 0 C-N-CA 126.74 2.016 . . . . 0.0 106.639 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.8 114.5 28.75 Favored 'General case' 0 C--N 1.372 1.575 0 CA-C-N 124.44 3.291 . . . . 0.0 108.504 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.5 t -86.18 129.92 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.265 -0.897 . . . . 0.0 111.213 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 39' ' ' GLU 0.285 0.5 OUTLIER -87.36 123.93 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.408 1.099 . . . . 0.0 108.991 174.626 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -115.76 -52.26 2.63 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.222 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -114.68 100.41 8.24 Favored 'General case' 0 CA--C 1.591 2.544 0 N-CA-C 102.144 -3.28 . . . . 0.0 102.144 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 36' ' ' ILE 0.254 6.3 pt-20 -42.69 -90.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 1 N-CA-C 123.84 4.755 . . . . 0.0 123.84 -178.598 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.0 158.22 29.52 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 127.084 2.278 . . . . 0.0 111.756 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.275 14.6 t -145.29 -32.24 0.39 Allowed 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.3 -106.87 1.0 Allowed Glycine 0 CA--C 1.542 1.734 0 N-CA-C 117.264 1.665 . . . . 0.0 117.264 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -146.06 95.14 2.58 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.934 1.294 . . . . 0.0 108.224 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.322 74.9 mt-10 73.29 175.76 0.27 Allowed 'General case' 0 N--CA 1.496 1.83 1 N-CA-C 123.163 4.505 . . . . 0.0 123.163 171.61 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.7 p -96.2 152.89 39.11 Favored Pre-proline 0 CA--C 1.572 1.789 0 CA-C-N 113.346 -1.752 . . . . 0.0 113.156 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.17 172.29 16.33 Favored 'Trans proline' 0 CA--C 1.572 2.414 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.1 ptm -112.97 166.54 11.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.712 -1.243 . . . . 0.0 114.018 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.302 0.4 OUTLIER -63.81 131.57 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 O-C-N 119.375 -2.078 . . . . 0.0 109.406 176.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.4 12.58 75.45 Favored Glycine 0 CA--C 1.568 3.36 0 N-CA-C 117.725 1.85 . . . . 0.0 117.725 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -83.22 144.87 29.49 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.765 1.782 . . . . 0.0 114.232 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.3 tpt85 -83.65 127.38 33.72 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 m -130.51 142.45 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 119.257 0.935 . . . . 0.0 111.743 -172.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -116.71 104.07 10.99 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 120.223 -1.548 . . . . 0.0 107.798 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.9 m -106.59 170.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 123.326 1.536 . . . . 0.0 114.662 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.86 116.47 10.78 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 168.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.252 10.2 p90 -114.86 148.98 37.84 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -174.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.9 m -120.03 146.26 46.06 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 163.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.5 141.8 8.64 Favored Glycine 0 CA--C 1.549 2.217 0 O-C-N 119.395 -2.066 . . . . 0.0 116.246 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -130.21 149.55 51.86 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.095 2.158 . . . . 0.0 114.312 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.2 tp -80.85 168.27 18.96 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.93 1.348 . . . . 0.0 107.946 168.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.298 0.0 OUTLIER -60.42 -27.34 67.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.233 2.309 . . . . 0.0 117.233 178.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -74.07 3.31 7.16 Favored 'General case' 0 CA--C 1.595 2.688 0 N-CA-C 114.438 1.274 . . . . 0.0 114.438 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.56 42.12 18.54 Favored Glycine 0 N--CA 1.504 3.178 0 O-C-N 119.914 -1.741 . . . . 0.0 114.185 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.6 m -116.93 115.59 25.77 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -78.58 92.81 4.74 Favored 'General case' 0 CA--C 1.588 2.424 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -67.91 -32.31 72.69 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 119.014 -2.304 . . . . 0.0 114.988 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -148.11 153.0 38.28 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 124.449 2.071 . . . . 0.0 112.571 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.9 p -155.62 90.85 1.26 Allowed 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 112.746 -2.025 . . . . 0.0 109.172 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 t -54.82 -34.45 62.82 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -53.07 -41.48 64.92 Favored 'General case' 0 CA--C 1.583 2.234 0 C-N-CA 125.99 1.716 . . . . 0.0 114.316 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.99 -39.04 30.88 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 124.908 1.283 . . . . 0.0 114.151 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -61.65 -20.77 63.77 Favored 'General case' 0 CA--C 1.578 2.056 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.371 3.1 ttmp? 107.24 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 127.425 2.29 . . . . 0.0 113.482 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.51 171.9 9.09 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 123.714 1.721 . . . . 0.0 112.339 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -99.16 -177.1 3.5 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.113 -1.403 . . . . 0.0 114.035 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.287 4.9 t80 -116.07 152.22 34.01 Favored 'General case' 0 CA--C 1.581 2.161 0 O-C-N 120.847 -1.158 . . . . 0.0 109.686 173.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.8 p -161.57 137.53 7.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 118.576 -2.577 . . . . 0.0 109.257 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.487 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.6 p90 -147.61 -175.8 5.0 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.429 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -127.52 119.76 26.76 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.01 106.49 0.08 Allowed 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 125.858 1.663 . . . . 0.0 113.479 -175.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.98 40.19 98.56 Favored Glycine 0 N--CA 1.513 3.773 0 N-CA-C 116.871 1.508 . . . . 0.0 116.871 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.84 -68.05 0.87 Allowed 'General case' 0 N--CA 1.506 2.374 0 CA-C-N 117.454 0.627 . . . . 0.0 112.638 -174.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.95 -58.78 2.57 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 126.012 3.007 . . . . 0.0 108.741 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.652 51.8 tp10 95.77 138.02 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.101 2 CA-C-N 107.241 -4.48 . . . . 0.0 116.576 165.176 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.338 30.4 m -95.94 -122.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 1 CA-C-N 103.667 -6.152 . . . . 0.0 107.183 -174.35 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.437 HG13 ' H ' ' A' ' 89' ' ' TRP . 25.9 pt -117.43 155.85 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 123.552 1.644 . . . . 0.0 108.624 169.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.261 2.5 mptt -64.67 -32.58 74.31 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.079 -1.419 . . . . 0.0 113.733 177.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.75 -35.28 76.0 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 117.266 -1.349 . . . . 0.0 111.652 167.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.437 ' H ' HG13 ' A' ' 86' ' ' ILE . 33.4 m0 -73.51 -45.17 55.42 Favored 'General case' 0 C--N 1.365 1.24 0 CA-C-N 120.896 1.68 . . . . 0.0 112.627 172.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.19 -38.21 73.32 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-N 120.379 1.445 . . . . 0.0 114.396 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.293 1.6 mp -67.59 -58.15 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.961 0 CA-C-N 119.547 1.067 . . . . 0.0 111.258 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.67 -41.34 97.42 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.265 4.9 t -63.31 -45.08 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 CA-C-N 120.235 1.379 . . . . 0.0 111.714 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.53 -38.03 29.22 Favored 'General case' 0 CA--C 1.583 2.212 0 CA-C-N 120.746 1.612 . . . . 0.0 114.438 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.8 p -91.79 17.47 9.0 Favored 'General case' 0 CA--C 1.596 2.729 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 16.2 ttt -111.44 141.34 45.12 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 119.215 -2.178 . . . . 0.0 114.883 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -98.0 150.46 21.36 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 116.407 2.002 . . . . 0.0 116.407 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.9 t -42.69 116.43 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.584 2.281 0 C-N-CA 125.515 1.526 . . . . 0.0 114.068 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.05 -35.44 4.44 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 118.888 2.315 . . . . 0.0 118.888 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.428 7.2 mt-10 -95.6 -154.28 0.43 Allowed 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 -175.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.14 155.74 41.13 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 119.225 3.046 . . . . 0.0 119.225 -170.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.6 m -145.64 153.7 41.31 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 112.177 -2.283 . . . . 0.0 113.134 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -110.84 122.59 48.24 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-O 124.726 2.203 . . . . 0.0 109.016 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 mt -83.45 130.27 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 CA-C-N 112.106 -2.315 . . . . 0.0 109.9 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.6 m -126.59 98.61 5.47 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 5.4 p -124.89 148.81 48.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -171.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -79.87 146.81 64.91 Favored Pre-proline 0 CA--C 1.58 2.131 0 CA-C-N 113.537 -1.665 . . . . 0.0 112.594 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -51.3 -19.86 7.21 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 N-CA-C 119.706 2.925 . . . . 0.0 119.706 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.15 -42.87 91.73 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 119.744 1.156 . . . . 0.0 113.739 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -85.77 7.12 24.95 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.907 1.283 . . . . 0.0 114.164 172.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.26 -120.0 0.09 Allowed 'General case' 0 CA--C 1.585 2.3 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.454 ' CD2' HD11 ' A' ' 127' ' ' LEU 0.262 4.0 m-85 -84.84 -2.78 58.19 Favored 'General case' 0 N--CA 1.521 3.085 0 CA-C-N 121.364 1.893 . . . . 0.0 115.007 -178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.2 -33.02 5.32 Favored Glycine 0 N--CA 1.502 3.065 1 N-CA-C 123.127 4.011 . . . . 0.0 123.127 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.0 t -64.98 -49.77 68.98 Favored 'General case' 0 CA--C 1.575 1.919 0 CA-C-N 119.965 1.882 . . . . 0.0 114.109 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -126.17 -16.43 5.51 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 118.977 2.954 . . . . 0.0 118.977 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.5 149.65 21.45 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-N 122.809 2.55 . . . . 0.0 113.235 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.479 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 5.3 t -82.26 118.13 70.87 Favored Pre-proline 0 CA--C 1.58 2.111 0 CA-C-O 117.001 -1.476 . . . . 0.0 108.716 177.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -33.03 -48.18 0.37 Allowed 'Trans proline' 0 CA--C 1.579 2.751 1 N-CA-C 123.398 4.345 . . . . 0.0 123.398 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.96 -24.65 8.2 Favored 'Trans proline' 0 CA--C 1.574 2.5 0 CA-C-N 125.492 2.997 . . . . 0.0 118.933 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -152.01 -20.21 0.18 Allowed 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 118.969 2.952 . . . . 0.0 118.969 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.479 ' HB ' ' H ' ' A' ' 117' ' ' SER . 88.3 mt -96.37 129.76 32.6 Favored Pre-proline 0 N--CA 1.503 2.176 0 CA-C-N 121.826 2.103 . . . . 0.0 114.603 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -96.12 172.98 1.0 Allowed 'Trans proline' 0 CA--C 1.593 3.447 0 C-N-CA 122.585 2.19 . . . . 0.0 112.688 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -55.73 -0.02 0.16 Allowed 'Trans proline' 0 CA--C 1.577 2.653 1 N-CA-C 122.58 4.031 . . . . 0.0 122.58 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -144.64 65.85 1.27 Allowed 'General case' 0 CA--C 1.582 2.182 0 CA-C-N 121.193 1.815 . . . . 0.0 112.487 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.04 110.74 7.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.019 -1.676 . . . . 0.0 109.57 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 88.7 m -59.5 156.92 12.28 Favored 'General case' 0 CA--C 1.588 2.431 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.454 HD11 ' CD2' ' A' ' 112' ' ' TYR . 97.3 mt -127.72 166.84 17.38 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 124.647 2.165 . . . . 0.0 114.371 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 51.8 t -143.35 115.69 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.861 0 CA-C-N 111.825 -2.443 . . . . 0.0 108.04 -173.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.282 2.5 m-85 -129.97 126.63 38.26 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-N 122.497 2.408 . . . . 0.0 110.904 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -99.19 105.0 17.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 119.494 -2.004 . . . . 0.0 105.966 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 t -115.65 129.38 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 122.138 0.971 . . . . 0.0 112.0 -170.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -100.57 144.28 29.73 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.719 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 44.0 tp -127.94 122.2 31.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.587 -0.696 . . . . 0.0 109.582 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -92.41 -48.44 6.65 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -160.48 158.85 30.03 Favored 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 125.445 1.498 . . . . 0.0 108.998 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.254 2.9 p90 -147.36 -90.49 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 110.305 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.425 80.1 tttt -114.73 -65.97 1.13 Allowed 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-N 125.557 3.799 . . . . 0.0 117.837 -178.545 . . . . . . . . 0 0 . 1 stop_ save_